Enanta Pharmaceuticals Inc (ENTA)
9.31
+0.23
(+2.53%)
USD |
NASDAQ |
Nov 21, 16:00
9.30
-0.01
(-0.11%)
After-Hours: 20:00
Enanta Pharmaceuticals Max Drawdown (5Y): 92.26% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2024 | 92.26% |
| September 30, 2024 | 92.26% |
| August 31, 2024 | 92.26% |
| July 31, 2024 | 92.26% |
| June 30, 2024 | 92.26% |
| May 31, 2024 | 92.26% |
| April 30, 2024 | 92.26% |
| March 31, 2024 | 92.26% |
| February 29, 2024 | 92.26% |
| January 31, 2024 | 92.26% |
| December 31, 2023 | 92.26% |
| November 30, 2023 | 92.26% |
| October 31, 2023 | 92.10% |
| September 30, 2023 | 89.50% |
| August 31, 2023 | 85.95% |
| July 31, 2023 | 84.71% |
| June 30, 2023 | 83.64% |
| May 31, 2023 | 81.42% |
| April 30, 2023 | 73.12% |
| March 31, 2023 | 69.83% |
| February 28, 2023 | 69.83% |
| January 31, 2023 | 69.83% |
| December 31, 2022 | 69.83% |
| November 30, 2022 | 69.83% |
| October 31, 2022 | 69.83% |
| Date | Value |
|---|---|
| September 30, 2022 | 69.83% |
| August 31, 2022 | 69.83% |
| July 31, 2022 | 69.83% |
| June 30, 2022 | 69.83% |
| May 31, 2022 | 69.83% |
| April 30, 2022 | 68.17% |
| March 31, 2022 | 68.17% |
| February 28, 2022 | 68.17% |
| January 31, 2022 | 68.17% |
| December 31, 2021 | 68.17% |
| November 30, 2021 | 68.17% |
| October 31, 2021 | 68.17% |
| September 30, 2021 | 68.17% |
| August 31, 2021 | 68.17% |
| July 31, 2021 | 68.17% |
| June 30, 2021 | 68.17% |
| May 31, 2021 | 68.17% |
| April 30, 2021 | 68.17% |
| March 31, 2021 | 68.17% |
| February 28, 2021 | 68.17% |
| January 31, 2021 | 68.17% |
| December 31, 2020 | 68.17% |
| November 30, 2020 | 68.17% |
| October 31, 2020 | 68.17% |
| September 30, 2020 | 68.17% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
59.60%
Minimum
Nov 2019
92.26%
Maximum
Nov 2023
74.62%
Average
69.00%
Median
Max Drawdown (5Y) Benchmarks
| NovaBay Pharmaceuticals Inc | 99.98% |
| Palatin Technologies Inc | 97.38% |
| iBio Inc | 99.97% |
| Theriva Biologics Inc | 99.81% |
| Oragenics Inc | 99.67% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -38.33 |
| Beta (5Y) | 0.5652 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 55.34% |
| Historical Sharpe Ratio (5Y) | -0.5608 |
| Historical Sortino (5Y) | -0.9771 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 25.91% |